Company intelligence
Modus Therapeutics Holding AB
We develop sevuparin to help patients with severe conditions and high unmet medical need.
Biotechnology Research
Stockholm, SE
6 employees
Founded 2011
1 public signals
About Modus Therapeutics Holding AB
Modus Therapeutics is a Swedish biotech company developing sevuparin for diseases with high unmet medical need. The Company’s near-term focus is to develop sevuparin for patients with sepsis/septic shock, a severe and often fatal condition.
Verified activity
Signals from Modus Therapeutics Holding AB
1 published signal